Plinest Polynucleotide Celora™ Vita
What it is Polynucleotide injectable Amino-acid + hyaluronic-acid injectable
Main concept Stimulates/supports regeneration and tissue repair Provides substrates/building blocks for dermal regeneration
Key ingredient Polynucleotides (PN-HPT®) 9 amino acids + low-molecular-weight HA
Main patient focus Repair, ageing, elasticity, texture, tissue quality Dehydration, dullness, early ageing, texture, elasticity
Hydration Good Particularly prominent
Fine lines Good potential Good potential
Skin firmness Good potential Good potential
Skin resilience/repair Particular strength More focused on supporting rebuilding
Glow/radiance Gradual Often an important early benefit
Under-eye use Strong indication for the appropriate Plinest formulation Generally more of a full-face treatment
Evidence base More established Newer, so less independent clinical evidence
Typical course Often 3–4 treatments Typically 3 treatments ~3 weeks apart
Downtime Usually mild/transient Usually mild/transient
Immediate volume No No meaningful volumising effect

Plinest Polynucleotide vs Celora Vita


The simplest way of thinking about the difference is:

Plinest is primarily a regenerative/repair treatment, whereas Celora Vita is primarily a skin “rebuilding materials”/biorestoration treatment.

They overlap considerably in the problems they aim to improve—fine lines, texture, elasticity, hydration and overall skin quality—but they approach those problems differently.

1. What actually happens with Plinest?

Plinest belongs to the polynucleotide family.

Rather than being a conventional filler, it is intended to improve the quality of the skin by influencing the biological environment in which skin repair and regeneration occur.

Polynucleotides have been investigated for their effects on processes including fibroblast activity, tissue repair, hydration and collagen/elastin-related skin quality.

That makes Plinest particularly interesting if your concern is:

progressively thinner or more fragile skin
loss of elasticity
fine lines
crepey texture
skin that looks aged rather than simply dehydrated
poor overall skin quality
certain periocular/under-eye concerns
skin that has become less resilient with age.

The important point is that Plinest isn’t trying to fill a wrinkle. The objective is to make the skin itself healthier and more resilient.

There is some genuinely encouraging evidence for polynucleotides. A 2025 systematic review identified nine studies involving 219 patients and found improvements in wrinkles, texture and elasticity in several studies, with generally mild and temporary adverse effects. However, the authors also emphasised that the evidence base is still relatively small and that the studies were predominantly low-to-moderate quality.

That distinction is important: “promising evidence” is not the same thing as definitive proof that polynucleotides outperform other regenerative treatments.

2. What is Celora Vita doing differently?

Celora Vita is a much newer treatment.

It isn’t a polynucleotide.

It contains nine amino acids together with low-molecular-weight hyaluronic acid. The rationale is that amino acids provide some of the raw materials required for processes involved in producing collagen, elastin and other components of the extracellular matrix, while the HA contributes to hydration.

So, conceptually:

Plinest:

“Let’s stimulate and support the skin’s regenerative processes.”

Celora Vita:

“Let’s provide the skin with some of the substrates and hydration it needs to rebuild healthy tissue.”

That’s an oversimplification of fairly complicated biology, but it is probably the most useful way for a patient to understand the distinction.

Celora Vita is being positioned particularly for skin that looks:

dull
dehydrated
tired
slightly lax
lacking elasticity
finely lined
generally less youthful in quality rather than requiring structural correction.

The manufacturer’s recommended protocol is three treatments approximately three weeks apart, and it is designed for full-face application including areas such as the forehead, periocular region, cheeks, perioral area and submental region.

3. Which one is likely to give you more “glow”?

I’d give Celora Vita a slight advantage if your primary complaint is dull, dehydrated, tired-looking skin.

That’s because hydration and restoration of skin radiance are central to its formulation and positioning.

You may see an improvement in hydration/radiance relatively early, while the longer-term improvements in texture and firmness are expected to develop progressively.

But this doesn’t mean Plinest won’t improve glow. Healthier, better-hydrated skin following polynucleotide treatment can certainly look brighter.

The difference is more about what the treatment is trying to achieve biologically than about one product being “glowy” and the other not.

4. Which would I favour for wrinkles?

This is more nuanced.

Fine, superficial lines

Either could be reasonable.

Celora Vita is particularly relevant when fine lines are accompanied by dehydration and reduced skin quality.

More mature, thin or fragile skin

I’d lean more towards Plinest.

The regenerative/repair rationale behind polynucleotides is particularly attractive when the problem isn’t simply dryness but a general deterioration in skin quality.

Deep expression lines

Neither should be thought of as a substitute for Botox.

For example, if your main issue is a strong frown line caused by repeated muscle movement, neither treatment is going to compete with botulinum toxin.

Likewise, neither is a conventional dermal filler and neither is primarily intended to restore lost facial volume.

5. What about skin laxity and collagen?

This is another area where the two treatments overlap.

Both are intended to support the biology associated with improved dermal quality, including collagen-related processes.

However, I would not interpret either treatment as a facelift in an injectable.

If someone has significant jowling, substantial cheek-volume loss or pronounced gravitational ageing, neither Plinest nor Celora Vita is going to physically reposition the tissues.

They are much better viewed as treatments for:

“How healthy and good-quality does my skin look?”

rather than:

“How much can we lift my face?”

That distinction is extremely important when deciding whether the treatment is worth the money.

6. Where Plinest has a significant advantage: evidence and experience

This is probably the biggest difference I would consider as a patient.

Plinest/polynucleotide treatments have been around longer and have a larger body of published literature behind the general treatment category.

The evidence isn’t perfect—the systematic review mentioned above explicitly says more high-quality research is needed—but there is at least a developing clinical literature supporting polynucleotide use.

Celora Vita is very new.

That doesn’t mean it doesn’t work.

It means that, as a patient, I would be more cautious about statements such as:

“Celora Vita is superior to polynucleotides”
“It produces more collagen”
“The results last longer”
“It is clinically proven to be better than Plinest.”

I haven’t found robust independent head-to-head clinical evidence demonstrating that.

In fact, much of the information currently available about Celora Vita comes from the manufacturer, distributors and aesthetic clinics rather than large independent randomised trials.

So if you’re choosing purely on strength of evidence, I’d currently give the advantage to Plinest/polynucleotides.

7. Which treatment would I choose for different patients?
Patient A — early 30s, dull and dehydrated skin

Celora Vita would be very attractive.

Imagine someone whose skin is:

tired-looking
dehydrated
slightly rough
beginning to develop fine lines
losing some youthful luminosity.

Celora Vita’s combination of amino acids and HA makes considerable sense for this presentation.

Patient B — 40s/50s, increasingly thin and crepey skin

I’d lean towards Plinest.

Especially if the issue is:

reduced elasticity
fine lines
crepiness
tissue quality
skin fragility
cumulative photoageing.
Patient C — under-eye ageing

I’d lean towards Plinest Eye, assuming the practitioner considers you suitable.

The periocular region is a particularly important distinction because there are Plinest formulations specifically designed for this type of application.

Celora Vita is more naturally thought of as a full-face biorestoration treatment.

Patient D — dehydrated skin with loss of firmness

This is where the decision becomes much harder.

Celora Vita may be attractive if hydration and radiance are the dominant concerns.

Plinest may be preferable if regeneration, resilience and longer-term tissue quality are the bigger concern.

Patient E — significantly sun-damaged/aged skin

I’d generally favour Plinest, potentially as part of a wider treatment programme.

But I would also ask whether the patient would get greater benefit from combining regenerative treatment with evidence-based treatments for pigmentation, photodamage and collagen remodelling.

8. What about combining them?

This is actually one of the most interesting possibilities.

I wouldn’t necessarily regard Plinest vs Celora Vita as a straightforward winner-takes-all competition.

Some practitioners are using the two treatments sequentially because they have different rationales.

One possible conceptual approach is:

Plinest → stimulate/support regeneration

followed by

Celora Vita → provide amino-acid substrates + hydration to support the rebuilding environment.

There are clinics already describing this type of approach, although I would be cautious about interpreting it as proven superiority: the rationale is biologically interesting, but we don’t yet have strong head-to-head evidence demonstrating that combination therapy produces better long-term outcomes than either treatment alone.

So I would not automatically pay for both simply because a clinic offers them together.

I’d want the practitioner to explain what additional problem the second treatment is addressing.

9. Which one hurts more?

Both involve multiple small injections, so neither is completely comfortable.

The experience depends heavily on:

injection technique
anatomical area
number of injection points
needle/cannula choice
anaesthetic used
your individual pain sensitivity.

Interestingly, practitioner reports around Celora Vita suggest that it can feel relatively gentle compared with some polynucleotide injections, although this is subjective rather than something I’d use as a deciding factor.

For either treatment, I’d ask the Renew Clinic:

“Do you use topical anaesthetic, and how long do you normally leave it on?”

That can make a surprisingly large difference.

10. Downtime

Neither is generally associated with the sort of downtime you’d expect from laser resurfacing or surgery.

However, “no downtime” does not mean “no visible evidence that you’ve had injections.”

You can potentially have:

small raised papules
redness
swelling
bruising
tenderness
injection marks.

With superficial injection techniques, small bumps can temporarily appear.

Published/clinical descriptions of Celora Vita report mild transient papules, redness or swelling that generally resolve relatively quickly.

Polynucleotide injections similarly commonly cause short-lived local reactions.

If you have an important event coming up, I wouldn’t schedule either treatment immediately beforehand.

11. What I would NOT expect from either

This is perhaps the most important patient expectation.

Neither treatment should be expected to:

dramatically lift sagging facial tissue
replace lost cheek volume
sculpt the jawline
eliminate deep wrinkles
reproduce the effect of a facelift
produce an immediate dramatic transformation.

Their strength is subtle improvement in skin quality.

The ideal result is usually something along the lines of:

“You look really well.”

rather than:

“You’ve obviously had something injected.”

That is actually one of the attractions of these treatments.

12. Safety: what should you ask the Renew Clinic?

Because both involve injections, I’d focus less on marketing claims and more on the clinician and protocol.

I’d ask:

Who will actually administer the treatment?
What professional registration do they hold?
Which exact Plinest product will I receive?
How many ml/vials will be used?
Which areas will be treated?
What is the proposed number of sessions?
What evidence do you use to recommend Plinest rather than Celora Vita for my skin?
Is there any reason I shouldn’t have either treatment?
What are your arrangements for dealing with complications?
What happens if I develop a significant swelling, infection or vascular complication?

That last question is particularly important with any injectable, irrespective of how “gentle” or “regenerative” the product is marketed as.

13. One thing I would be particularly careful about

Don’t let the terminology make these treatments sound more proven than they are.

Words such as:

regenerative
biostimulator
cellular regeneration
fibroblast activation
collagen stimulation
skin remodelling
biorestoration

sound extremely scientific—and the underlying biology can indeed be scientifically plausible.

But biological plausibility isn’t the same as demonstrated clinical superiority.

The systematic review of polynucleotides is actually quite reassuring in this respect because it acknowledges both sides: promising improvements have been observed, but the evidence base remains limited and better-quality research is needed.

For Celora Vita, I’d be even more cautious because it is a much newer product.

My patient-focused verdict

If I were comparing the two without knowing anything else about your skin, I’d summarise them like this:

Plinest Polynucleotides

I’d favour Plinest if the priority is:

ageing skin
loss of elasticity
crepey/thin skin
fine lines
skin resilience
tissue repair
under-eye ageing
a treatment with a more established evidence base.

Overall: the more established regenerative option.

Celora Vita

I’d favour Celora Vita if the priority is:

dehydration
dullness
lack of radiance
tired-looking skin
early ageing
fine superficial lines
improving overall skin quality
a relatively gentle full-face “skin restoration” approach.

Overall: the newer, more hydration/substrate-focused option.

If you’re asking me which I’d choose…

For an older or more photodamaged face with thinning, crepey or less resilient skin: I’d lean Plinest.

For relatively young/early ageing skin that is predominantly dehydrated, dull and lacking glow: I’d lean Celora Vita.

For a combination of significant ageing + dehydration: I’d ask the clinician whether sequential Plinest and Celora Vita is genuinely justified for your particular skin rather than automatically buying a package.

And importantly, I would not pay a premium for Celora Vita on the assumption that “newer” means “better.” At present, Plinest has the advantage in terms of the maturity of the clinical evidence, while Celora Vita is an interesting newer approach with a plausible mechanism but a much smaller independent evidence base.